USD 0.02
(3.88%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 252.26 Thousand USD | -44.24% |
2022 | 452.42 Thousand USD | 2.81% |
2021 | 440.06 Thousand USD | 6.13% |
2020 | 414.66 Thousand USD | 14.61% |
2019 | 361.8 Thousand USD | 1.61% |
2018 | 356.06 Thousand USD | -37.59% |
2017 | 570.47 Thousand USD | 0.0% |
2015 | 445.28 Thousand USD | -25.59% |
2014 | 598.42 Thousand USD | 119798.74% |
2013 | 499.11 USD | 0.0% |
2009 | 537 Thousand USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 246.27 Thousand USD | -5.59% |
2024 Q1 | 260.86 Thousand USD | 3.41% |
2023 Q4 | 252.26 Thousand USD | -10.63% |
2023 Q2 | 452.42 Thousand USD | 0.0% |
2023 Q1 | 452.42 Thousand USD | 0.0% |
2023 FY | 252.26 Thousand USD | -44.24% |
2023 Q3 | 282.26 Thousand USD | -37.61% |
2022 Q1 | 440.06 Thousand USD | -0.0% |
2022 Q2 | 452.42 Thousand USD | 2.81% |
2022 Q3 | 452.42 Thousand USD | 0.0% |
2022 FY | 452.42 Thousand USD | 2.81% |
2022 Q4 | 452.42 Thousand USD | 0.0% |
2021 Q3 | 436.56 Thousand USD | 0.25% |
2021 FY | 440.06 Thousand USD | 6.13% |
2021 Q2 | 435.49 Thousand USD | -7.42% |
2021 Q1 | 470.39 Thousand USD | 0.0% |
2021 Q4 | 440.06 Thousand USD | 0.8% |
2020 FY | 414.66 Thousand USD | 14.61% |
2019 FY | 361.8 Thousand USD | 1.61% |
2018 FY | 356.06 Thousand USD | -37.59% |
2017 FY | 570.47 Thousand USD | 0.0% |
2015 FY | 445.28 Thousand USD | -25.59% |
2014 Q4 | 598.42 USD | 1.69% |
2014 Q2 | 572.61 USD | 6.08% |
2014 FY | 598.42 Thousand USD | 119798.74% |
2014 Q1 | 539.81 USD | 8.15% |
2014 Q3 | 588.50 USD | 2.78% |
2013 Q4 | 499.11 USD | -27.48% |
2013 FY | 499.11 USD | 0.0% |
2013 Q3 | 688.27 USD | 13.54% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | 606.21 USD | 0.0% |
2010 Q2 | 486.39 Thousand USD | -9.42% |
2010 Q1 | 537 Thousand USD | 0.0% |
2010 Q3 | 486.39 Thousand USD | 0.0% |
2009 Q2 | 537 Thousand USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | 537 Thousand USD | 0.0% |
2009 Q4 | 537 Thousand USD | 0.0% |
2009 Q3 | 537 Thousand USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
China Medicine Corporation | 9.5 Million USD | 97.346% |
DH Enchantment Inc. | 412.64 Thousand USD | 38.866% |
Exlites Holdings International, Inc. | - USD | -Infinity% |
Itonis, Inc. | 910.44 Thousand USD | 72.292% |
MediPal Holdings Corporation | 9.61 Million USD | 97.378% |
PD-Rx Pharmaceuticals, Inc. | - USD | -Infinity% |
Pharmagen, Inc. | 4588.24 USD | -5398.143% |
Suzuken Co., Ltd. | 11.91 Million USD | 97.882% |